Zoran (ZRAN) Misses Q1 EPS by 5c; Guides Q2 Below, Expects Profitability in H211
Tweet
Share
E-mailGet Alerts ZRAN Hot Sheet
Price: $8.17 --0%
Financial Fact:
Shares used to compute basic and diluted net loss per share: 49.81M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Shares used to compute basic and diluted net loss per share: 49.81M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Zoran Corporation (Nasdaq: ZRAN) reported Q1 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $84.9 million versus the consensus estimate of $83.27 million.
Zoran Corporation sees Q2 2011 EPS of ($0.43) - ($0.43), versus prior guidance of $97.04 and the consensus of ($0.18). Zoran Corporation sees Q2 2011 revenue of $80-$85 million.
Zoran expects a significant increase in revenues for the third quarter of 2011 and expects to be profitable on a non-GAAP basis in the second half of 2011.
Zoran Corporation sees Q2 2011 EPS of ($0.43) - ($0.43), versus prior guidance of $97.04 and the consensus of ($0.18). Zoran Corporation sees Q2 2011 revenue of $80-$85 million.
Zoran expects a significant increase in revenues for the third quarter of 2011 and expects to be profitable on a non-GAAP basis in the second half of 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
